Summary
PKI Chart
Revvity Q2 Earnings Call Highlights
Revvity NYSE: RVTY reported second-quarter results above its expectations and raised its full-year outlook, citing continued strength in diagnostics, improving demand from pharmaceutical and biotechnology customers, and growing orders tied to artificial intelligence-enabled drug discovery workflows.
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up
Revvity beats Q2 earnings and sales estimates as Diagnostics growth, wider margins and strong cash flow support a higher 2026 outlook.
Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates
Revvity (RVTY) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.18 per share a year ago.
PerkinElmer, Inc. (PKI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has PerkinElmer, Inc. ever had a stock split?
PerkinElmer, Inc. Profile
| Professional Services Industry | Industrials Sector | Prahlad R. Singh CEO | XMEX Exchange | US7140461093 ISIN |
| US Country | 11,000 Employees | 23 Oct 2026 Last Dividend | 4 Jun 2001 Last Split | - IPO Date |
Overview
Revvity, Inc., previously known as PerkinElmer, Inc., marks a significant name in the health sciences industry, offering comprehensive solutions, technologies, and services across the globe, including the Americas, Europe, Asia, and other international territories. With its inception in 1937 and headquarters in Waltham, Massachusetts, Revvity has grown to serve an expansive range of clients, including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Operating through two main segments - Life Sciences and Diagnostics - Revvity, Inc. brings forward a suite of instruments, reagents, informatics, software, and much more, catering to a wide array of testing, screening, and research needs in the health sciences sector.
Products and Services
Revvity, Inc.'s product portfolio and services are vast, covering various needs within the life sciences and diagnostics fields. Here's an overview of their most notable offerings:
- AutoDELFIA, BACS-on-Beads, BIOCHIPs, and similar products: These are used for the testing and screening of genetic abnormalities, disorders, and diseases. They serve a critical role in early detection and screening processes for conditions such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
- chemagic, Chitas, DELFIA, DELFIA Xpress, and related instruments: These instruments and technologies are essential for genomic workflows, supporting applications in oncology, immunodiagnostics, drug discovery, and more. They provide the necessary tools for researchers and healthcare practitioners to analyze and understand genetic material and protein interactions.
- JANUS, LabChip, LifeCycle, LimsLink, and similar software and systems: Key in informatics and laboratory management, these software solutions and systems optimize the operations within laboratories, improving efficiency, data management, and processing in research and diagnostic settings.
- Migele, MultiPROBE, NEXTFLEX, NextPrep, and other reagents and assay platforms: These products are designed for specific applications within the fields of diagnostics and life sciences research, including DNA sequencing, protein analysis, and more. They are integral to the processes of detecting, analyzing, and understanding complex biological materials.
- T-SPOT, Twister, VariSpec, ViaCord, VICTOR 2D, Zephyr, and more brand names: Under these brand names, Revvity, Inc. offers a diverse range of products that cater to different aspects of health sciences, from diagnostic tests for infectious diseases to advanced instruments for genetic and proteomic research. Each brand specializes in a unique area of the health sciences, providing specialized tools and technologies to their respective fields.
